Evidence map›Paper›PMID 42020358›Full record

ArticleSignal transduction and targeted therapy2026

Temporal assessment of behavior in Parkinson's visual hallucinations via a multidimensional analysis strategy.

Quan-Xin Zhang, Yi-Xuan Zhang, Chen-Chen Jiang, Jia-Wen Cheng, Shen-Jia Tao, Yun-Long Pan, Fukunaga Kohji, Shu-Yang Chen, Xing-Feng Mao, Li Zhang and 2 more

Abstract read
In one paragraph

Article in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Quan-Xin Zhang *Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Key Laboratory of Cardiovascular & Cerebrovascular Medicine; School of Pharmacy, Nanjing, China.
Yi-Xuan Zhang *Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Key Laboratory of Cardiovascular & Cerebrovascular Medicine; School of Pharmacy, Nanjing, China.ORCID http://orcid.org/0000-0001-9781-6281
Chen-Chen Jiang *Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Key Laboratory of Cardiovascular & Cerebrovascular Medicine; School of Pharmacy, Nanjing, China.
Jia-Wen ChengKey Laboratory of Modern Toxicology of Ministry of Education; Department of Physiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Shen-Jia TaoMedical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Key Laboratory of Cardiovascular & Cerebrovascular Medicine; School of Pharmacy, Nanjing, China.
Yun-Long PanKey Laboratory of Modern Toxicology of Ministry of Education; Department of Physiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Fukunaga KohjiDepartment of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.
Shu-Yang ChenMedical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Key Laboratory of Cardiovascular & Cerebrovascular Medicine; School of Pharmacy, Nanjing, China.
Xing-Feng MaoKey Laboratory of Modern Toxicology of Ministry of Education; Department of Physiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Li ZhangInstitute of Brain Science, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China. neuro_zhangli@163.com.
Ying-Mei LuKey Laboratory of Modern Toxicology of Ministry of Education; Department of Physiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China. lufx@njmu.edu.cn.ORCID http://orcid.org/0000-0003-3187-4344
Feng HanMedical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Key Laboratory of Cardiovascular & Cerebrovascular Medicine; School of Pharmacy, Nanjing, China. fenghan169@njmu.edu.cn.ORCID http://orcid.org/0000-0002-4868-3491

Funding

National Natural Science Foundation of China (National Science Foundation of China) 2411078National Natural Science Foundation of China (National Science Foundation of China) 82171249National Natural Science Foundation of China (National Science Foundation of China) 82204352National Natural Science Foundation of China (National Science Foundation of China) 82230114
6 · The paper itself

Abstract

Visual hallucination (VH) is a common nonmotor symptom of Parkinson's disease (PD). However, the lack of reliable animal models and quantitative assessment tools poses significant challenges for mechanism and intervention research in this area. Here, we developed a novel PD-related visual hallucination (PDVH) model by administering benzhexol hydrochloride, which can induce hallucinatory phenotypes in PD model mice. On the basis of this model, we used a multidimensional behavioral analysis framework to identify a hallucination-related hunching state (HHS) that is strongly associated with hallucinatory episodes. This state is characterized by a sustained hunching posture accompanied by prolonged staring and embedded head twitching. By constructing a spontaneous behavior transition map, we found that the emergence of spontaneous behaviors is highly dependent on the immediately preceding state, revealing that the core hallucinatory features are structured and predictable at the level of spontaneous behavior. The relative fractions and transition probabilities of staring and head twitching allow high-throughput identification of PDVH mice and reflect temporal dynamics of the hallucination process. Our findings demonstrate that this approach enables high spatiotemporal resolution acquisition and analysis of behaviors associated with PDVH, offering a robust experimental framework for investigating PDVH mechanisms at the circuit level and developing targeted therapeutic strategies.

Indexed as

Behavior, AnimalHallucinationsParkinson DiseaseAnimalsDisease Models, AnimalHumansMaleMice

Identifiers

PMID42020358
PMCPMC13102970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.